Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis.

Entenza JM, Hohl P, Heinze-Krauss I, Glauser MP, Moreillon P.

Antimicrob Agents Chemother. 2002 Jan;46(1):171-7.

2.

In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci.

Hebeisen P, Heinze-Krauss I, Angehrn P, Hohl P, Page MG, Then RL.

Antimicrob Agents Chemother. 2001 Mar;45(3):825-36.

3.

Phenyl beta-methoxyacrylates: a new antimalarial pharmacophore.

Alzeer J, Chollet J, Heinze-Krauss I, Hubschwerlen C, Matile H, Ridley RG.

J Med Chem. 2000 Feb 24;43(4):560-8.

PMID:
10691682
4.

Structure-based design of beta-lactamase inhibitors. 1. Synthesis and evaluation of bridged monobactams.

Heinze-Krauss I, Angehrn P, Charnas RL, Gubernator K, Gutknecht EM, Hubschwerlen C, Kania M, Oefner C, Page MG, Sogabe S, Specklin JL, Winkler F.

J Med Chem. 1998 Oct 8;41(21):3961-71.

PMID:
9767633
5.

Synthesis and structure-activity relationship of (lactamylvinyl)cephalosporins exhibiting activity against staphylococci, pneumococci, and enterococci.

Heinze-Krauss I, Angehrn P, Guerry P, Hebeisen P, Hubschwerlen C, Kompis I, Page MG, Richter HG, Runtz V, Stalder H, Weiss U, Wei CC.

J Med Chem. 1996 Apr 26;39(9):1864-71.

PMID:
8627610

Supplemental Content

Loading ...
Support Center